HIV Gene Therapy
Survival of Genetically Engineered Blood Cells in HIV-1 Human Study Reported
Published in Medical Letter on the CDC and FDA, February 14th, 2000
The study, a Phase I clinical trial sponsored by Enzo Therapeutics, is being conducted at the University of California in San Francisco and is viewed as a critical step forward in the company's development of a gene medicine for the treatment of HIV-1 infection.
Dean Engelhardt, PhD, Enzo, presenting at the 7th Retroviruses and Opportunistic Infections Conference in San Francisco, reported that engineered cells have now been observed in circulation for a period exceeding 4 months. Furthermore, he said that these engineered cells...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Regulatory Issues
Study Finds Federal Scientific Data Often Flawed When Not Reviewed - Low-Fat Diet
Reductions in Fat Can Enhance Vitamin E Transport - Compliance
Number of Pills May Be Just as Important as the Type of Medication - Drug Resistance
Test Helps Doctors Pick AIDS Drugs - Preeclampsia
Test May Prove To Be Marker for Life-Threatening Pregnancy Complication - Transmission
Danger HIV through Oral Sex High - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
